Iværksætterselskabet Redo Neurosystems vil lære patienter at kontrollere deres hjerneaktivitet i forbindelse med smerte – og dermed lindre smerten uden brug af medicin. Ideen og potentialet er så stort, at Bristol-Myers Squibb og Fonden For Entrepreneurskab netop har præmieret den med 25.000 kr.
Kan man træne sin hjerne til ikke at føle smerte?
Ja, mener det spritnye iværksætterselskab Redo Neurosystems, der har udviklet en ny behandlingstype til smertelindring – en såkaldt neurofeedback-behandling, der har som ambition at lære patienter at kontrollere deres hjerneaktivitet i forbindelse med smerte – og dermed dulme smerten uden brug af medicin.
Allerede abonnent? Log Ind.
(Senior) Regulatory Science Specialist - IWA Consulting 
Clinical Business Process Manager - Genmab 
Associate Formulation Scientist, Oral Formulation Research - Novo Nordisk Head of Development Operations - Genmab 
Analytical Coordinator (Senior scientist) – Permanent position, Symphogen Senior Formulation Scientist, Oral Formulation Research - Novo Nordisk 
Drug Safety Advisor - ALK 
Associate Director, PV/GCP Quality Assurance - Y-mAbs Therapeutics 
Medarbejder til regulatorisk afdeling - Pharma Nord 
Clinical Supply Coordinator - Klifo Chief Physician - Clinical Innovation Centre, Novo Nordisk Senior Contract Manager - Genmab Radiochemist in CMC Development - Y-mAbs Therapeutics Senior Manager, IT QA - Genmab Principal Biostatistician - ALK eTMF Manager - Klifo Associate Medical Director, Clinical Development, Y-mAbs Therapeutics Clinical Trial Assistant Specialist - ALK Global Medical Affairs Lead - Y-mAbs Therapeutics Clinical Trial Manager - Genmab Principal Formulation Scientist, Oral Formulation Research - Novo Nordisk 
Market Access/Business Development Manager - Orifarm Formulation Specialist, Oral Formulation Research - Novo Nordisk Kvalitetskoordinator til Quality Control - ALK Associate Director, Biostatistics - Genmab 
